Physician profile
Peter Lee
NPI 1710143698
$4,851.52
in general payments reported to CMS, 2019-2025
14 companies · $55.52 in 2025
The $55.52 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,972 · 2020: $299 · 2021: $30.18 · 2022: $286 · 2023: $143 · 2024: $2,066 · 2025: $55.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,814 · Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,814.39 |
| Food and Beverage | $449.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,971.06 | 2019-2024 | Excelsiusgps Robotic Navigation System, Xlif, Excelsius Deformity |
| Nuvasive, INC. | $373.83 | 2019 | |
| Arthrex, INC. | $321.90 | 2024 | |
| Si-Bone, INC. | $190.16 | 2022-2023 | |
| Richard Wolf Medical Instruments Corp. | $165.74 | 2020 | |
| Depuy Synthes Sales INC. | $158.19 | 2023-2024 | Symphony, X-Pac |
| Alphatec Spine, INC | $157.77 | 2019-2021 | |
| Medtronic USA, INC. | $133.04 | 2020 | |
| Amplify Surgical, INC. | $121.49 | 2024 | Dualx and Dualportal |
| Medtronic, INC. | $110.64 | 2022 | |
| Invictus Surgical Incorporated | $59.88 | 2024 | |
| Medical Device Business Services, INC. | $32.30 | 2019 | |
| Blueprint Medicines Corporation | $28.65 | 2025 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $26.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.